tm
Seeing Is Believing
tm
Seeing Is Believing
9 Meters Biopharma's activity chart (see below) currently has 8 price targets and 10 ratings on display.
Analysts average stock forecasts to be materialized ratio is 70.83% with an average time for these price targets to be met of 52.5 days.
Most recent stock forecast was given by SAMANTHA SEMENKOW from CITI on 18-May-2023. First documented stock forecast 30-Jun-2020.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 13-Feb-2023
$0.75
$0.73 (3650.00%)
$1.7
3 years 5 months 13 days ago
(18-May-2023)
1/3 (33.33%)
$0.28 (59.57%)
23
Buy Since 30-Jun-2020
$40
3 years 7 months 11 days ago
(20-Mar-2023)
3/3 (100%)
$-126.15 (-75.93%)
47
Buy Since 08-Jul-2021
$240
$239.98 (1199900.00%)
4 years 4 months 9 days ago
(22-Jun-2022)
2/2 (100%)
$73.85 (44.45%)
117
What is NMTR (9 Meters Biopharma) average time for price targets to be met?
Which analyst most recently updated their price target on NMTR (9 Meters Biopharma)?
Which analyst has the current lower performing score on NMTR (9 Meters Biopharma) with a proven track record?
Which analyst has the most public recommendations on NMTR (9 Meters Biopharma)?
Which analyst is the currently most bullish on NMTR (9 Meters Biopharma)?
Which analyst is the currently most reserved on NMTR (9 Meters Biopharma)?
